C4A and autoimmune thrombocytopenic purpura: The observation of a statistically significant decrease in mean C4 levels in treatment-naïve patients compared with levels in those receiving treatment supports the findings of Cheloff et al., who reported that complement may significantly contribute to platelet loss in a subset of ITP patients.